Do you want to read an article? Please log in or register.
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/j.chest.2019.11.007.
RECOMMENDED
COPD
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/j.rmed.2021.106645
COMMENTED
AsthmaCOPDEmphysema
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
Lancet Respir Med.
Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R 3rd, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER8; SPIROMICS investigators
doi: 10.1016/
COMMENTED
COPD
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Alexander Turk, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Magnussen H, Lucas S, Lapperre T, Quint JK, Dandurand RJ, Roche N, Papi A, Price D, Miravitlles M, Respiratory Effectiveness Group (REG).
doi: 10.1186/s12931-021-01615-0
RECOMMENDED
COPD
Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups
Respir Med.
Bakerly ND, Woodcock A,
Collier S, Leather DA, New JP,
Crawford J, Harvey C, Vestbo J,
Boucot I
doi: 10.1016/j.rmed.2018.12.016.
RECOMMENDED
COPD
Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Chest
Rothnie KJ, Quint JK
doi: 10.1016/j.chest.2020.02.069
RECOMMENDED
COPD
Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
Chest.
Rothnie KJ, Quint JK
doi: 10.1016/j.chest.2020.02.069.
AsthmaCOPD
Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey
Int J Chron Obstruct Pulmon Dis
Ding B, Small M
doi: 10.2147/COPD.S136314.
RECOMMENDED
COPD
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Marín JM, Mateos L, Roldán J, Echave-Sustaeta JM, Pascual-Guardia S, Pardo MV, Velasco B, Jones CE, Kilbride S, Lipson DA
doi: 10.1177/1753466620963021